Streptomycin
- PMID: 32310346
- Bookshelf ID: NBK555886
Streptomycin
Excerpt
Streptomycin is the first discovered aminoglycoside antibiotic, originally isolated from the bacteria Streptomyces griseus. It is now primarily used as part of the multi-drug treatment of pulmonary tuberculosis. It has additional activity against several aerobic gram-negative bacteria. This activity will discuss the indications, mechanism of action, and contraindications of using streptomycin in both children and adults. It will also describe the administration, dosing, and monitoring of streptomycin. Additionally, it will touch on the adverse event profile and other key factors to keep in mind as a healthcare team when using streptomycin as an antibiotic agent to treat pulmonary tuberculosis or other aerobic gram-negative infections.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Zhu M, Burman WJ, Jaresko GS, Berning SE, Jelliffe RW, Peloquin CA. Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis. Pharmacotherapy. 2001 Sep;21(9):1037-45. - PubMed
-
- Daniel TM. Selman Abraham Waksman and the discovery of streptomycin. Int J Tuberc Lung Dis. 2005 Feb;9(2):120-2. - PubMed
-
- Ball AP, Gray JA, Murdoch JM. Antibacterial Drugs today: II. Drugs. 1975;10(2):81-111. - PubMed
-
- Camba SA, Alterthum F, De Carvalho Lima LP. Some evidences for the hypothesis of active transport of streptomycin in Pseudomonas aeruginosa. Chemotherapy. 1976;22(6):341-5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources